FIMM joined the EU-LIFE (European Life Sciences Institutes for Excellence) network comprising of thirteen top biomedical research institutes from Europe, including, e.g. Centre of Genomic Regulation (CRG, Barcelona, Spain; EMBL Partnership) in 2013. The Consortium Agreement was signed in December 2013. The purpose of the network is to support and strengthen European research excellence, and its impact on health systems and society. Partners discuss latest developments in European science policy and produce documents for policy makers and stakeholders in life sciences. In addition, several working groups define and share best practices, as well as design joint activities on topics of common interest, such as technology transfer, translational research, research training and science communication. EU-LIFE will work closely with EU commission, European Research Council (ERC), Innovative Medicines Initiative (IMI) and other European organization and will help to ensure best practices are distributed in Europe between research institutions.